SEC 13F Intelligence

EIDXGBPEIDOS THERAPEUTICS INC

CUSIP 28249H104 · Yahoo Finance ↗ · Google Finance ↗

Eidos Therapeutics Inc (EIDXGBP) has 63 institutional holders in Filings Flow’s 13F database, together reporting 0 shares worth $0 as of Q2 2021.

Institutional Holders
1
Q2 2021
Reported Value
$0
Ticker
EIDXGBP
Quarters Tracked
5

Ownership Trend

Institutional holders
Q4 ’18: 44Q4 ’18Q1 ’19: 46Q1 ’19Q2 ’19: 61Q2 ’19Q3 ’19: 63Q3 ’19Q2 ’21: 1Q2 ’21filingsflow.com
Total reported value
Q4 ’18: $96MQ4 ’18Q1 ’19: $258MQ1 ’19Q2 ’19: $278MQ2 ’19Q3 ’19: $299MQ3 ’19Q2 ’21: $0Q2 ’21filingsflow.com

Holders

Manager% of PortfolioValueSharesQuarter
MetLife Investment Management, LLC$19.6B AUM0.00%$265,8085.6KQ1 2024

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.